JAK1-IN-8
JAK1-IN-8, a potent JAK1 inhibitor (IC50[1].
Product Specifications
CAS Number
[1973485-18-5]
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/jak1-in-8.html
Purity
95.0
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(C1CC1)NC2=CN3C(C4=CC(F)=C(CN5CCS(=O)(CC5)=O)C=C4)=CC=CC3=N2
Molecular Formula
C22H23FN4O3S
Molecular Weight
442.51
References & Citations
[1]Jin Li, et al. Composés d'imidazo[1,2-a]pyridin-2-ylamine substitués, compositions pharmaceutiques et leurs méthodes d'utilisation. Patent WO2016119700A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
JAK1; JAK2; JAK3
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15125380 1 Vial
Lentiviral mouse Klra4 shRNA (UAS) - Lentiviral mouse Klra4 shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details 134126 200 µL
SYK (Tyrosine-protein Kinase SYK, Spleen Tyrosine Kinase, DKFZp313N1010, FLJ25043, FLJ37489)
Sign In for Pricing
View Details 
TL510094V 500 µL Each
Mup1 Mouse shRNA Lentiviral Particle (Locus ID 17840)
Sign In for Pricing
View Details